Matthew Kaplan
Stock Analyst at Ladenburg Thalmann
(2.82)
# 1,658
Out of 5,113 analysts
26
Total ratings
62.5%
Success rate
19%
Average return
Main Sectors:
Stocks Rated by Matthew Kaplan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UTHR United Therapeutics | Maintains: Buy | $319 → $344 | $517.13 | -33.48% | 9 | Oct 31, 2024 | |
| URGN UroGen Pharma | Maintains: Buy | $48 → $54 | $22.80 | +134.65% | 1 | Jun 14, 2024 | |
| TGTX TG Therapeutics | Maintains: Buy | $39 → $40 | $30.98 | +29.12% | 3 | May 2, 2024 | |
| LQDA Liquidia | Maintains: Buy | $15 → $30 | $34.53 | -13.12% | 2 | Dec 21, 2023 | |
| ARDX Ardelyx | Maintains: Buy | $7.5 → $8.5 | $5.68 | +49.65% | 4 | Aug 3, 2023 | |
| AVDL Avadel Pharmaceuticals | Maintains: Buy | $15 → $16 | $21.47 | -25.48% | 1 | May 2, 2023 | |
| KPRX Kiora Pharmaceuticals | Reiterates: Buy | $1,071 | $2.16 | +49,483.33% | 2 | Feb 8, 2023 | |
| XAIR Beyond Air | Maintains: Buy | $340 → $460 | $0.91 | +50,349.66% | 1 | Jun 29, 2022 | |
| LPCN Lipocine | Upgrades: Buy | $51 | $4.25 | +1,100.00% | 1 | Dec 10, 2020 | |
| COGT Cogent Biosciences | Initiates: Buy | $16 | $39.55 | -59.54% | 1 | Oct 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $45 | $5.27 | +753.89% | 1 | Jan 22, 2020 |
United Therapeutics
Oct 31, 2024
Maintains: Buy
Price Target: $319 → $344
Current: $517.13
Upside: -33.48%
UroGen Pharma
Jun 14, 2024
Maintains: Buy
Price Target: $48 → $54
Current: $22.80
Upside: +134.65%
TG Therapeutics
May 2, 2024
Maintains: Buy
Price Target: $39 → $40
Current: $30.98
Upside: +29.12%
Liquidia
Dec 21, 2023
Maintains: Buy
Price Target: $15 → $30
Current: $34.53
Upside: -13.12%
Ardelyx
Aug 3, 2023
Maintains: Buy
Price Target: $7.5 → $8.5
Current: $5.68
Upside: +49.65%
Avadel Pharmaceuticals
May 2, 2023
Maintains: Buy
Price Target: $15 → $16
Current: $21.47
Upside: -25.48%
Kiora Pharmaceuticals
Feb 8, 2023
Reiterates: Buy
Price Target: $1,071
Current: $2.16
Upside: +49,483.33%
Beyond Air
Jun 29, 2022
Maintains: Buy
Price Target: $340 → $460
Current: $0.91
Upside: +50,349.66%
Lipocine
Dec 10, 2020
Upgrades: Buy
Price Target: $51
Current: $4.25
Upside: +1,100.00%
Cogent Biosciences
Oct 14, 2020
Initiates: Buy
Price Target: $16
Current: $39.55
Upside: -59.54%
Jan 22, 2020
Initiates: Buy
Price Target: $45
Current: $5.27
Upside: +753.89%